Health-Care Stock Has Its Say

By: Dylan Sykes - AllPennyStocks.com News

Monday, July 6, 2020

There were more developments on the health front Monday, amid dire news involving the coronavirus pandemic.

In New York, the health-care sector picked up 1.2%, while in Canada, the hike was 1.3%, although there were no Canadian small-cap stocks with new tidings.

Boca Raton, Fla-based Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) announced it is in licensing discussions for a novel monoclonal antibody (mAB) to treat brain cancer. The Company plans to grow its product pipeline through an active program of acquisition, in-licensing and sub-licensing of new technologies.

The company, a development-stage biomedical company focusing on novel treatments for rare diseases today announced it is in licensing discussions for a novel monoclonal antibody (mAB) to treat brain cancer. CTYX plans to grow its product pipeline through an active program of acquisition, in-licensing and sub-licensing of new technologies.

CTYX shares galloped 25% by noon hour Monday to 0.875 cents, on 6.3 million shares.

Copyright © 2020 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.